Abstract:
A method of predicting response to chemotherapy in a patient with cancer is described. The method comprises the steps of incubating an ADCC-capable molecule, an immune response modulator, a cancer cell line that expresses a target of the ADCC-capable molecule, and a sample of the patient's blood, for a period of time, determining an ADCC response of the cancer cell line, comparing the ADCC response with a reference ADCC response, and predicting the patient's response to chemotherapy based on the comparison. In one aspect, the cancer is a HER2+ cancer, the ADCC-capable molecule is an antibody targeting HER2, and the cancer cell lines is a HER2+ cancer cell line.
Abstract:
The invention provides a navigation device comprising a docking portion configured to securely adhere to a surface and a unit having at least one of a visual, an audio or tactile indicator. The present invention provides a device which the user attaches to a wall or door or ground surface entered on the way into a building. A number of fixed devices then assist the user to retrace their route out of the building. In addition, the device can be configured to transmit essential information to a user located outside the building. The devices can also be configured to form a novel navigation communication system.
Abstract:
A microfluidic device for detection of an analyte in a fluid is described. The microfluidic device comprises a substrate having a first surface defining entrances to one or more chambers defined in the substrate, surfaces of the chambers defining a second surface of the substrate, the first surface being modified for selective targeting and capture of at least one analyte to operably effect a blocking of the entrance to at least one of the chambers, and wherein a response characteristic of the microfluidic device is operably varied by the blocking of the entrance to the at least one of the chambers, thereby providing an indication of the presence of the analyte within the fluid.
Abstract:
The invention includes Clostridial neurotoxin derivatives containing at least two light chain endopeptidase domains, and nucleic acids encoding such Clostridial neurotoxin derivatives. In preferred embodiments, the invention includes methods and compositions for the treatment of inflammatory disorders(such as arthritis); chronic pain, such as neuropathic painand inflammatory pain through the use of such Clostridial neurotoxin derivatives, including those derived from an intact BoNT/A having an LC/E- derived endopeptidase joined to the LC/A endopeptidase.
Abstract:
The present teaching provides a three wheel zero emission dumper vehicle (100), the vehicle comprising a chassis (150), the chassis supporting: two fixed front wheels (180), a single steering rear wheel (190), and a load carrying assembly, wherein the vehicle is configured such that a distribution of weight supported by the chassis is such that a centre of gravity of the vehicle is maintained within a triangle formed by the contact of the wheels on the ground in both loaded and unloaded states of the load carrying assembly.
Abstract:
A label comprising: a nanoparticle wherein the nanoparticle surface is functionalised to comprise at least one dendrimer having at least one activatable functional group for conjugating a target analyte to the functionalised nanoparticle, wherein the dendrimer has a stabilizing effect on the zeta potential at the nanoparticle surface. Such a label is desirable since the stabilizing effect results from an increase in the zeta potential at the nanoparticle surface. The dendrimer functionalised nanoparticle may be conjugated to a detection molecule which detects a target analyte. Use of the labels in bioassays allow detection of ultralow LODs.
Abstract:
The formation of a barrier layer within individual channels or cavities of a microfluidic device is described. The barrier layer is effected through a gas phase deposition process, desirably implemented in a plasma environment.
Abstract:
The present invention is directed to a lateral flow assay device for the monitoring and measuring of coagulation and method thereof. Ideally, the invention is directed to a lateral capillary flow device for the monitoring and/or measurement of coagulation in a liquid sample wherein the device comprises a non-porous substrate with a zone for receiving a sample and a defined flow path zone wherein a clotting agent is deposited on at least part of the defined flow path zone to accelerate the coagulation of the liquid sample, enable the formation of an evenly distributed clot along the defined flow path zone and to result in the change in flow rate or cessation of flow of the liquid sample along the defined flow path zone.
Abstract:
A multi-well plate (1) for a biological assay comprising a plate frame (4) attached to a support substrate (7) through a gasket (5) wherein the plate frame (4) defines side walls for a plurality of wells (2) and the gasket (5) comprises a plurality of holes (6), whereby the holes (6) of the gasket (5) are substantially aligned with the wells (2) defined by the plate frame (4) such that the support substrate (7) forms a base for the wells (2) and wherein the side walls of the wells (2) comprise an absorbed layer of blocking agent. The substrate (7) may comprise functional surface amine groups for binding to a protein.
Abstract:
An object/test material interaction microti iridic device comprising a sample inlet adapted to receive a fluid sample comprising a plurality of objects, an outlet adapted to output the fluid sample from the device, at least one internal surface defining a flow cavity within the device, wherein the flow cavity extends between and is connected to the sample inlet and the outlet for flow of the fluid sample through the flow cavity, the flow cavity comprises a test area to which at least one test material is attached and which is situated in the flow cavity for flow of the fluid sample over the test area, and the flow cavity has an aspect ratio which, when the flow cavity is substantially filled by the fluid sample, provides a substantially constant shear force between the test area and the fluid sample flowing over the test area. The invention further comprises a system incorporating the device, methods of use of the device and system, and methods of analysing interactions.